Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers.
Department of Pharmacology, University of Padova.
R
R
Padrini
D
D
Piovan
S
S
Bova
R
R
Moretto
G
G
Cargnelli
M
M
Ferrari
D000375:Aging / Q000378:metabolism; D000818:Animals; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics*; D004110:Diltiazem / Q000493:pharmacokinetics; D004334:Drug Administration Schedule; D006168:Guinea Pigs; D006801:Humans; D007536:Isomerism; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D008991:Monitoring, Physiologic; D009543:Nifedipine / Q000493:pharmacokinetics; D010641:Phenotype; D014700:Verapamil / Q000493:pharmacokinetics
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine